# John Bridgewater

Source: https://onco.cc/people/john-bridgewater/  
OnCo record `john-bridgewater` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Senior author of the UK's two standard-setting biliary trials, ABC-02 and BILCAP, chief investigator of ABC-06, and UK lead of the first-line precision medicine trial SAFIR-ABC10.

## Summary

John Bridgewater is professor of medical oncology at the UCL Cancer Institute and a consultant at UCLH. He was senior author on ABC-02 (gemcitabine plus cisplatin as first-line standard) and BILCAP (adjuvant capecitabine), chief investigator of ABC-06 (second-line FOLFOX) and leads the National Cancer Research Institute biliary tract subgroup. He leads the UK arm of SAFIR-ABC10, sponsored by UCL and UCLH, which profiles tumours and matches patients with cholangiocarcinoma or gallbladder cancer to one of seven targeted therapies, and co-authored the 2023 British Society of Gastroenterology cholangiocarcinoma guideline.

## Fields

- Kind: Person
- Last checked: 2026-09-24
- Tags: biliary; trialist; uk
- Role: Professor of Medical Oncology, UCL Cancer Institute; Consultant Medical Oncologist, University College London Hospitals; Medical Adviser, AMMF
- Specialisms: Biliary tract cancer; Carcinoma of unknown primary; Gastrointestinal oncology; Precision medicine trials

## Sources

- UCL profile: https://profiles.ucl.ac.uk/824-john-bridgewater
- UCLH consultant page: https://www.uclh.nhs.uk/our-services/find-consultant/professor-john-bridgewater

## Connected records

- people: [Mairéad McNamara](https://onco.cc/people/mairead-mcnamara/)
- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- drugs: [Capecitabine](https://onco.cc/drugs/capecitabine/), [Cisplatin](https://onco.cc/drugs/cisplatin/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/)
- institutions: [AMMF, the Cholangiocarcinoma Charity](https://onco.cc/institutions/ammf/), [University College London Hospitals / UCL Cancer Institute](https://onco.cc/institutions/uclh/)
- trials: [ABC-02](https://onco.cc/trials/abc-02/), [ABC-06](https://onco.cc/trials/abc-06/), [BILCAP](https://onco.cc/trials/bilcap/)

---
JSON: https://onco.cc/api/v1/entities/john-bridgewater.json